American Academy of Neurology Annual Meeting (AAN)

Worse strokes are more likely to occur in patients who are resistant to aspirin. Better ways to identify those patients are needed.

Here's a handy synopsis of a “hands-on” review of the current state of monitoring disease and treatment decision making in patients with multiple sclerosis.

This new guideline could change the approach many physicians take to treating a first seizure--and could improve patients’ lives.

Highlights of the first large study to describe the characteristics of post-traumatic headache and treatment response in children are summarized here.

A novel drug-device may not only be a promising non-oral triptan acute migraine treatment, but may be more efficacious than its oral counterpart.

Can the EEG predict neurological outcomes in post-anoxic encephalopathy from out-of-hospital cardiac arrest? What effect does TIA have on stroke risk in women migraineurs? What's the relationship between MS and vitamin D levels in minority populations?

Quick, how many of the following-eslicarbazepine, ezogabine, parampanel-do you recognize? These new entries into the medical armamentarium were highlighted at the AAN 2015 Annual Meeting.

A non-psychoactive component of the marijuana plant, cannabidiol in liquid form decreased seizures by an average of 50% across multiple types of severe epilepsy.

Advances in neurology science and patient care continue to make news even before the doors to the AAN 2015 Annual Meeting officially open on Saturday. These are the top stories.

A major advance in epilepsy treatment may be found in the first direct brain responsive neurostimulator, upcoming AAN meeting will have an epilepsy focus, and other top stories.

ADHD lowers the quality of life in adults with epilepsy; epilepsy is associated with social deprivation and increased risk of venous thromboembolism: details of these recent findings in this slide show.